Skip to main content
Fig. 2 | Renal Replacement Therapy

Fig. 2

From: Long-term iron accumulation in dialysis patients treated with ferric citrate hydrate: a single-center, 80-week retrospective study in Japan

Fig. 2

Change in mean serum phosphate and FCH dosage in HD and PD patients. The number of HD patients (n) with concomitant use of intravenous iron (40 mg saccharated iron oxide) given at the end of hemodialysis treatment once a week. The number (n) of FCH-treated patients receiving HD and PD over 80 weeks. HD hemodialysis, PD peritoneal dialysis, FCH ferric citrate hydrate, P serum phosphate, IV iron intravenous iron

Back to article page